Procedure
Stem Cell Collection
Stem Cell Collection is a medical procedure with 5 clinical trials. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
200%(4 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_2
2
40%
Ph early_phase_1
1
20%
Ph phase_4
1
20%
Ph phase_3
1
20%
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
40.0%
2 of 5 finished
Non-Completion Rate
60.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(3)
Detailed Status
Completed2
Terminated2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
Trials by Status
completed240%
withdrawn120%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_2
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
NCT01746173
completedphase_2
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
NCT01329900
completedphase_4
Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma
NCT01731886
terminatedphase_3
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
NCT02489500
withdrawnearly_phase_1
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
NCT02976441
Clinical Trials (5)
Showing 5 of 5 trials
NCT01746173Phase 2
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
NCT01329900Phase 2
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
NCT01731886Phase 4
Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma
NCT02489500Phase 3
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
NCT02976441Early Phase 1
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
All 5 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 5